Status:
NOT_YET_RECRUITING
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
MainSquare Co. (dba 'Teleo')
Conditions:
Anxiety
Mood Disorders
Eligibility:
All Genders
5-14 years
Phase:
NA
Brief Summary
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifical...
Detailed Description
This study aims to examine the impact of tailored telehealth psychotherapy environments on clinical outcomes in the context of pediatric mental health treatment. Researchers will conduct a full-scale ...
Eligibility Criteria
Inclusion
- Diagnosed with a mood and/or anxiety disorder
- Have proficiency to participate in psychotherapy in English
- Scheduled to begin therapy at one of the study sites
- RCADS score \> 65
Exclusion
- \- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2027
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT07155707
Start Date
September 15 2025
End Date
September 15 2027
Last Update
September 23 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohana Center for Child and Adolescent Behavioral Health
Monterey, California, United States, 93940
2
Stanford University
Stanford, California, United States, 94305